Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses

BACKGROUND. There are limited data on the clinical benefits of adding surgical resection in patients with focally progressive gastrointestinal stromal tumor (GIST). This study aims to compare the clinical outcomes of resection plus imatinib dose escalation or maintenance (S group) with imatinib dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hyungwoo, Ryu, Min‐Hee, Lee, Yongjune, Park, Young Soo, Kim, Ki‐Hun, Kim, Jwa Hoon, Park, Yangsoon, Lee, Sun Mi, Kim, Chan Wook, Kim, Beom Soo, Yoo, Moon‐Won, Kang, Yoon‐Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Sarcomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975948/
https://www.ncbi.nlm.nih.gov/pubmed/31315961
http://dx.doi.org/10.1634/theoncologist.2019-0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975948/
https://www.ncbi.nlm.nih.gov/pubmed/31315961
http://dx.doi.org/10.1634/theoncologist.2019-0009

Ejemplares similares